Paraneoplastic Skin Syndromes in Dogs: When Skin Changes Signal Internal Cancer

Based on peer reviewed veterinary research · For educational purposes only · Updated October 2026 · 9 min read

What Are Paraneoplastic Skin Syndromes in Dogs?

Paraneoplastic skin syndromes are skin diseases triggered by a tumor located elsewhere in the body, usually through hormones, growth factors, or immune reactions the tumor produces, rather than by cancer cells spreading into the skin. The skin becomes a visible readout of a hidden internal process.

In a landmark review, Turek (2003) catalogued the cutaneous paraneoplastic syndromes recognized in dogs and cats and noted that they are uncommon but clinically important, because the skin lesions frequently appear weeks or months before the tumor itself causes obvious illness. Recognizing the pattern can shorten the time to diagnosis considerably.

The best documented canine syndromes include feminization from Sertoli cell tumors (estrogen excess), nodular dermatofibrosis (firm skin nodules linked to kidney tumors in German Shepherds), superficial necrolytic dermatitis (crusting of the paw pads and muzzle, occasionally caused by a glucagon-secreting pancreatic tumor), and paraneoplastic pemphigus (an autoimmune blistering disease associated with certain internal tumors). Endocrine alopecia caused by adrenal or pituitary tumors also sits on this spectrum.

None of these conditions can be cured with skin treatment alone. The skin improves when the underlying tumor is identified and treated, which is why a thorough internal workup is the cornerstone of management.

What Causes Skin Changes to Appear With Internal Tumors?

Tumors can change the skin through several distinct mechanisms, and the mechanism usually predicts the lesion pattern.

Hormone production. Sertoli cell tumors can secrete estrogen. Excess estrogen causes symmetrical hair loss on the flanks and perineum, darkening of the skin (hyperpigmentation), an enlarged prepuce and mammary glands, and attraction of other male dogs. Hayes and Pendergrass (1976) found that cryptorchid (retained) testicles carry a more than 10-fold higher risk of testicular tumors, which is why undescended testicles in older dogs deserve attention. Adrenal tumors that overproduce cortisol cause thin skin, bilateral alopecia, comedones (blackheads), and sometimes calcinosis cutis (chalky mineral deposits in the skin).

Inherited cancer syndromes. Nodular dermatofibrosis in German Shepherds is caused by a mutation in the canine BHD (folliculin) gene, inherited in an autosomal dominant pattern. Lingaas and colleagues (2003) showed that the same mutation drives multifocal renal cystadenocarcinoma and, in females, uterine leiomyomas. The firm skin nodules on the legs and head often precede kidney signs by years.

Metabolic disruption. In superficial necrolytic dermatitis, severe depletion of plasma amino acids starves the rapidly dividing epidermis. Outerbridge and colleagues (2002) documented markedly low amino acid concentrations in 36 dogs with confirmed disease. Most cases are driven by liver disease, but a minority stem from a glucagonoma (a glucagon-secreting pancreatic tumor).

Immune cross-reactivity. In paraneoplastic pemphigus, the immune system produces autoantibodies against skin adhesion proteins in response to the tumor. Elmore and colleagues (2005) described this in a dog with splenic sarcoma, with severe erosions of the mouth and mucocutaneous junctions.

How Do Veterinarians Diagnose Paraneoplastic Skin Disease?

Diagnosis works in two directions at once: confirming what the skin lesion is, and finding the tumor responsible for it.

Skin-level tests come first. Skin scrapings, tape cytology, and impression smears rule out mites, yeast, and bacteria, which frequently complicate the picture. Skin biopsy with histopathology is the most important single test, because several paraneoplastic syndromes have characteristic microscopic features. Superficial necrolytic dermatitis, for example, shows a distinctive red, white, and blue layered pattern in the epidermis. Direct immunofluorescence and serology help confirm paraneoplastic pemphigus.

Tumor-level tests follow. Depending on the pattern, your veterinarian may recommend a complete blood count, serum chemistry, urinalysis, testicular palpation and ultrasound, abdominal ultrasound of the liver, pancreas, adrenal glands, and kidneys, thoracic radiographs, adrenal function testing, plasma amino acid or glucagon measurement, and genetic testing for the BHD mutation in German Shepherds. Fine needle aspiration of any internal mass guides next steps.

If you are trying to make sense of a new skin change at home, our Dog Skin Condition Checker can help you organize what you are seeing before your appointment. It does not replace a veterinary workup, especially when paraneoplastic disease is on the list.

Signs and Symptoms to Watch For

Paraneoplastic lesions tend to share a few features: they are symmetrical, they do not respond to routine allergy or infection treatment, and they often appear in middle-aged to older dogs. The table below summarizes the major canine patterns.

Treatment Options for Paraneoplastic Skin Syndromes

Treating the tumor is the treatment for the skin. When the source is removed or controlled, paraneoplastic lesions frequently regress.

Castration of a dog with a Sertoli cell tumor typically resolves feminization within a few months, provided the tumor has not spread. Adrenalectomy or medical management addresses cortisol-driven alopecia. Surgical removal of a glucagonoma can reverse superficial necrolytic dermatitis, although many of these tumors have already spread by the time of diagnosis. Nodular dermatofibrosis tracks the progression of kidney disease, so management centers on monitoring and treating the renal tumors. Paraneoplastic pemphigus requires both tumor therapy and immunosuppression. Our detailed guides on Sertoli Cell Tumors and Feminizing Skin Changes and Pancreatic Disease and Superficial Necrolytic Dermatitis cover those pathways in more depth.

Supportive skin care matters in parallel. Thin, crusted, or eroded skin loses its barrier function, and Malassezia pachydermatis (yeast) and Staphylococcus pseudintermedius (bacteria) exploit the gap. Secondary overgrowth adds itch, odor, and greasy scale, which can mask the underlying pattern and make dogs more uncomfortable during cancer treatment.

Topical antimicrobials address that secondary layer without adding systemic drug load. Yeast Dermatitis Spray combines chlorhexidine gluconate, which disrupts bacterial and fungal cell membranes, with ketoconazole, which blocks ergosterol synthesis in yeast cell walls. It is an FDA-registered OTC veterinary drug listed on DailyMed, not a cosmetic. It supports the skin surface while your veterinarian manages the root cause; it does not treat the tumor. Learn more about recognizing overgrowth on our Yeast Infections in Dogs page.

Always check with your veterinarian before applying topicals to open erosions or before bathing a dog that is undergoing chemotherapy or recovering from surgery.

Can Paraneoplastic Skin Syndromes Be Prevented?

The syndromes themselves cannot always be prevented, but several steps reduce risk or shorten the time to diagnosis.

Address retained testicles. Because cryptorchid testicles carry a markedly higher tumor risk, veterinarians generally recommend removing them. Routine testicular palpation in older intact males catches asymmetric enlargement early.

Screen at-risk breeds. German Shepherd breeders can use genetic testing for the BHD mutation to avoid producing affected puppies, and owners of carriers can schedule periodic kidney imaging.

Treat unexplained skin disease as a clue. Symmetrical hair loss, new nodules, or crusting that fails to respond to standard therapy in a dog over seven years old warrants bloodwork and imaging rather than repeated rounds of the same treatment. Fine needle aspiration of any new lump, described in our guide to Fine Needle Aspirates for Dog Skin Lumps, is a quick first step.

Keep the skin surface healthy during treatment. Gentle, regular hygiene of folds, paws, and crusted areas helps limit secondary infection while the internal disease is managed. Track any changes with photographs so your veterinarian can compare progress over time.

Frequently Asked Questions

Can skin problems in dogs be a sign of cancer?

Yes. Paraneoplastic syndromes are skin changes caused by an internal tumor, such as symmetrical hair loss from an estrogen-secreting Sertoli cell tumor or skin nodules linked to kidney cancer in German Shepherds. They often appear before other signs of the tumor.

What is the most common paraneoplastic skin syndrome in dogs?

Feminization syndrome from Sertoli cell tumors is among the most commonly recognized. It causes symmetrical flank hair loss, darkened skin, and enlarged nipples in male dogs, and retained testicles carry a more than 10-fold higher tumor risk.

What is nodular dermatofibrosis in German Shepherds?

It is an inherited condition causing multiple firm skin nodules, usually on the legs, caused by a BHD gene mutation that also drives kidney cancer (renal cystadenocarcinoma). Lingaas et al. (2003) identified the mutation.

Will my dog's skin improve if the tumor is removed?

Often, yes. Castration usually resolves Sertoli cell feminization within a few months, and removing a glucagonoma can reverse superficial necrolytic dermatitis. Outcomes depend on whether the tumor has spread.

Sources

1. Turek MM. Cutaneous paraneoplastic syndromes in dogs and cats: a review of the literature. Veterinary Dermatology. 2003;14(6):279-296.
2. Lingaas F, Comstock KE, Kirkness EF, et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Human Molecular Genetics. 2003;12(23):3043-3053.
3. Outerbridge CA, Marks SL, Rogers QR. Plasma amino acid concentrations in 36 dogs with histologically confirmed superficial necrolytic dermatitis. Veterinary Dermatology. 2002;13(4):177-186.
4. Elmore SA, Basseches J, Anhalt GJ, Cullen JM, Olivry T. Paraneoplastic pemphigus in a dog with splenic sarcoma. Veterinary Pathology. 2005;42(1):88-91.
5. Hayes HM Jr, Pendergrass TW. Canine testicular tumors: epidemiologic features of 410 dogs. International Journal of Cancer. 1976;18(4):482-487.
6. Miller WH, Griffin CE, Campbell KL. Muller and Kirk's Small Animal Dermatology. 7th ed. St. Louis: Elsevier; 2013.

Related Reading

• Sertoli Cell Tumors and Feminizing Skin Changes in Male Dogs
• Hepatocutaneous Syndrome in Dogs: Signs & Management
• Pemphigus in Dogs: Autoimmune Blistering Disease

E. Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Research basis: All Vetified content references peer reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.